Trial Profile
Angiotensin converting enzyme (ACE) inhibition and mechanisms of skeletal muscle weakness in chronic obstructive pulmonary disease (COPD): a double-blind, randomised, placebo-controlled, parallel trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Fosinopril (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 27 Nov 2015 New trial record